🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

[Mechanism of polyphyllin Ⅱ in improving DEHP-induced learning and memory impairment via targeting CK2b and activating Akt-CREB pathway].

PMID: 42011619 · DOI: 10.19540/j.cnki.cjcmm.20251117.701 · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2026 · Feng Qiu, Chen-Xi Wei, Li-Jun Gong, Yun Xiang, Zi-Yang Zhou, Xiu-Li Zhang
📄 Abstract

This study aimed to explore the effect and mechanism of polyphyllin Ⅱ in improving di(2-ethylhexyl)phthalate(DEHP)-induced learning and memory impairment. In the experiment, male C57BL/6 mice were randomly divided into five groups: a control group, a model group(exposed to 5 mg·kg~(-1) DEHP), and polyphyllin Ⅱ groups(5 mg·kg~(-1) DEHP + 0.5 mg·kg~(-1) polyphyllin Ⅱ, DEHP + 1 mg·kg~(-1) polyphyllin Ⅱ, and DEHP + 2 mg·kg~(-1) polyphyllin Ⅱ). The learning and memory function of mice was tested using the Morris water maze. The hippocampal neuron structure was detected by Nissl staining. The expression of casein kinase Ⅱ subunit beta(CK2b), protein kinase B(Akt)-cAMP response element binding protein(CREB) pathway-related proteins, as well as postsynaptic density protein 95(PSD95) and synapsin 1 was determined by immunofluorescence and Western blot. The brain-derived neurotrophic factor(BDNF) expression was measured by enzyme-linked immunosorbent assay(ELISA). The results showed that compared with the control group, DEHP induced learning and memory impairment, as well as hippocampal neuronal apoptosis in mice. Additionally, DEHP downregulated CK2b, inhibited the Akt-CREB pathway, and downregulated the PSD95, synapsin1, and BDNF expression. After polyphyllin Ⅱ administration, DEHP-induced learning and memory impairment was significantly improved, with inhibited hippocampal neuronal apoptosis, restored CK2b expression, reactivated Akt-CREB pathway, as well as restored expression of PSD95, synapsin1, and BDNF. Furthermore, the surface plasmon resonance(SPR) experiment of N2a cells demonstrated that polyphyllin Ⅱ targeted CK2b and stabilized its expression. After using siRNA to inhibit CK2b, the neuroprotective effect of polyphyllin Ⅱ was also significantly inhibited, and neuronal apoptosis was reinduced. In conclusion, polyphyllin Ⅱ can ameliorate DEHP-induced learning and memory impairment, with its potential mechanism involving the Akt-CREB pathway activation via CK2b upregulation, which leads to restored PSD95 and synapsin1 expression, and synaptic plasticity, as well as inhibited neuronal apoptosis, ultimately exerting a neuroprotective effect. This study suggests that polyphyllin Ⅱ possesses a neuroprotective effect and has potential application value in improving cognitive impairment.

Confidence: 0.3 · 15 полей извлечено
Идентификация (6 полей)
Target
CK2b
0.95
Alt. target
casein kinase Ⅱ subunit beta
0.95
Protein family
casein kinase Ⅱ subunit
0.90
Functional class
kinase
0.90
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
Polyphyllin II targets CK2b, stabilizes its expression, activates the Akt-CREB pathway, restores PSD95 and synapsin1 expression, and inhibits neuronal apoptosis.
0.95
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
Inhibits neuronal apoptosis
0.90
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
Akt-CREB pathway, PSD95, synapsin1, BDNF
0.90
Downstream (physiol)
Synaptic plasticity, neuroprotection
0.85
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
hippocampal neurons
0.90
In vitro
N2a cells
0.95
In vivo
male C57BL/6 mice exposed to DEHP and treated with polyphyllin II
0.95
In silico
0.00
Genetic association
siRNA inhibition of CK2b in N2a cells
0.90
Ex vivo
0.00
Animal model
male C57BL/6 mice
0.95
Diet/model
DEHP exposure (5 mg/kg) to induce learning and memory impairment
0.95
Клиника (11 полей)
Drug
polyphyllin Ⅱ
1.00
Indication
0.00
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00